Pharmacists in Bomoseen, VT Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Andrea R Hubbard Maclauchlan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 34 Route 30n, Bomoseen, VT 05732 Phone: 802-468-5777 Fax: 802-468-5818 |
Hannah Mary Kussel, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 34 Route 30 North, Bomoseen, VT 05732 Phone: 802-468-5777 |
Ms. Tammy Ann Delbianco, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 34 Route 30 North, Bomoseen, VT 05732 Phone: 802-468-5777 Fax: 802-468-5818 |
 Thomas Maurice Spencer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 275 Route 30 N, Bomoseen, VT 05732 Phone: 802-468-5800 Fax: 802-468-5811 |
News Archive
Threefold increase in polio cases in Afghanistan concerns experts
The New York Times examines how after years of decline, the number of recorded polio cases in Afghanistan tripled in 2011 to 76, following only 25 cases in 2010, raising concerns among international health experts that polio is seeing a resurgence, "particularly since some of the cases erupted far outside the disease's traditional areas in Afghanistan."
Legislative update: Georgia GOP lawmakers push to dismantle health law; abortion funding issues reheating
The Atlanta Journal-Constitution reports that Georgia's three physician members of Congress have been particularly active in the push to take apart the health law. Meanwhile, later this week, the abortion debate is likely to again take center stage in the House of Representatives.
"We are going to make sure healthcare is affordable and accessible for everybody": SEIU
"This is a moment of profound change for this country - from kitchen tables to town halls to the floor of the Senate, this nation is engaged in a vigorous and heated debate about how we rebuild our economy, solve our national healthcare crisis and restore the American Dream.
InterMune reaches definitive agreement with Vidara to sell Actimmune
InterMune, Inc. today announced that it has reached a definitive agreement with Vidara Therapeutics International Limited (Vidara) to sell its rights to Actimmune (interferon gamma-1b) in a cash transaction valued at $55 million plus a two-year royalty stream.
› Verified 1 days ago